Amdocs’ layoffs fail to halt share slide
The stock has tumbled more than 20% in three weeks, dragging the company's valuation down to its lowest level since 2020.
Three weeks ago, it was reported that Amdocs is planning a sweeping restructuring plan centered on another major round of layoffs, cutting an estimated 7% to 10% of its global workforce. Investors initially welcomed the news. Shares ticked up in immediate trading, reflecting a familiar Wall Street belief that aggressive cost-cutting paves a quick path back to profitability and growth.
The optimism didn't last.
Since the beginning of June, Amdocs shares have plunged by more than 20%, wiping out all post-restructuring gains and dragging the company’s market cap down to roughly $5.54 billion. The selloff leaves the telecom software provider trading at its lowest valuation since March 2020. In fact, if you exclude the brief market panic at the onset of the Covid-19 pandemic, Amdocs hasn't been worth this little since 2015.
This sharp reversal suggests a troubling shift in sentiment: investors may no longer see these upcoming layoffs as a sign of renewal, but rather as evidence of deeper, structural challenges for a company struggling to prove it can still generate meaningful growth.
The workforce reductions mark the first major move by incoming President and CEO Shimie Hortig, who took the helm at the end of March following the retirement of longtime CEO Shuky Sheffer. Hortig inherited a company that has spent years trying to balance cost management with a shifting, unpredictable telecom market.
Out of Amdocs' 29,000 global employees, about 5,000 are based in Israel. This current restructuring is expected to hit hundreds of local staff alongside thousands more worldwide.
Crucially, these cuts are far from a one-off. Over the past few years, Amdocs has repeatedly turned to layoffs to streamline operations. In 2023, the company eliminated roughly 2,700 jobs across two separate rounds. Another 1,500 positions were cut in 2024, followed by several hundred more in 2025.
While leadership previously framed the latest restructuring as a strategic redesign to "strengthen its global leadership position", even noting that the strategic importance of its Israeli operations would be reinforced, Wall Street is looking past the corporate phrasing. Three weeks after the announcement, the market's judgment is clear. Investors are demanding to see sustainable growth, not just a shrinking headcount, and until Amdocs delivers, the floor remains hard to find.
